Experienced in IgG4-Related Disease

Cecilia N. Pisoni

Argentinian Society Of Rheumatology, B, AR 
Experienced in IgG4-Related Disease
Argentinian Society Of Rheumatology, B, AR 
OverviewLocationsClinical Research

Overview

Cecilia Pisoni practices in Argentinian Society Of Rheumatology, Argentina. Ms. Pisoni is rated as an Experienced expert by MediFind in the treatment of IgG4-Related Disease. Her top areas of expertise are Systemic Lupus Erythematosus (SLE), Polymyalgia Rheumatica, Rhizomelic Pseudopolyarthritis, and Lupus Nephritis.

Her clinical research consists of co-authoring 40 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of IgG4-Related Disease.

Gender
Female

Locations

Argentinian Society Of Rheumatology, B, Argentina
Other Locations
Province of Buenos Aires, H.I.G.A San Martín
La Plata, B, Argentina
Puerto Galvan, B, Argentina
Buenos Aires, C, Argentina

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: November 23, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
View 1 Less Clinical Trial

40 Total Publications

Causes and associated factors with hospitalization in patients with systemic lupus erythematosus: Data from lupus multi-center registry in Argentina.
Causes and associated factors with hospitalization in patients with systemic lupus erythematosus: Data from lupus multi-center registry in Argentina.
Journal: Lupus
Published: April 05, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Pisoni's expertise for a condition
ConditionClose
    View All 17 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile